- Joined
- Sep 13, 2007
- Messages
- 1,002
I've been looking up many studies using oral AAS in humans and most of the findings seem positive pertaining liver toxicity. Here's a snippet where Halotestin was used in Hemodialysis patients a dose of 30mg/day for men:
"
Fluoxymesterone was administered to 14 severely anemic patients with chronic renal failure stabilized with maintenance hemodialysis. Clinically, significant improvement in erythropoiesis was seen within 3 to 6 months of androgen therapy in 13 of the 14 patients, as reflected by a reduction in transfusion requirements and an increase in hematocrit value. The increase in effective erythropoiesis was documented by the erythroid iron turnover and was accompanied usually by either an increase in measurable serum levels of erythropoietin or a reduction in the marrow transit time, suggesting that the androgen acted primarily by stimulating erythropoietin production. This response did not depend on the presence of residual renal tissue. In the doses given (10 mg/day for women; 30 mg/day for men), fluoxymesterone therapy was unassociated with significant toxicity. "
There are many more, but you get the point.
"
Fluoxymesterone was administered to 14 severely anemic patients with chronic renal failure stabilized with maintenance hemodialysis. Clinically, significant improvement in erythropoiesis was seen within 3 to 6 months of androgen therapy in 13 of the 14 patients, as reflected by a reduction in transfusion requirements and an increase in hematocrit value. The increase in effective erythropoiesis was documented by the erythroid iron turnover and was accompanied usually by either an increase in measurable serum levels of erythropoietin or a reduction in the marrow transit time, suggesting that the androgen acted primarily by stimulating erythropoietin production. This response did not depend on the presence of residual renal tissue. In the doses given (10 mg/day for women; 30 mg/day for men), fluoxymesterone therapy was unassociated with significant toxicity. "
There are many more, but you get the point.